Cellosaurus U2OS tGFP-ADCYAP1R1 (CVCL_B5WM)
| Cell line name | U2OS tGFP-ADCYAP1R1 |
|---|---|
| Synonyms | ADCYAP1R1-tGFP_U2OS; PAC1-tGFP |
| Accession | CVCL_B5WM |
| Resource Identification Initiative | To cite this cell line use: U2OS tGFP-ADCYAP1R1 (RRID:CVCL_B5WM) |
| Comments | Population: Caucasian. Characteristics: Has been designed to assay potential agonists/antagonists against ADCYAP1R1, modulating its activation and the following redistribution process inside the cells (Innoprot=P30214). Characteristics: Transfected with ADCYAP1R1 N-terminally tagged with turboGFP. Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:242; ADCYAP1R1. Genetic integration: Method=Transfection/transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata). Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. |
| Sequence variations |
|
| Disease | Osteosarcoma (NCIt: C9145) Osteosarcoma (ORDO: Orphanet_668) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_0042 (U2OS) |
| Sex of cell | Female |
| Age at sampling | 15Y |
| Category | Cancer cell line |
| Cross-references | |
| Cell line collections (Providers) | Innoprot; P30214 |
| Encyclopedic resources | Wikidata; Q112041875 |
| Entry history | |
| Entry creation | 17-Mar-2022 |
| Last entry update | 19-Dec-2024 |
| Version number | 8 |